VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NEOG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NEOGNeogen Corporation
$9.10$2.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNEOGCash Flow

Neogen Corporation (NEOG) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow remains highly volatile, swinging from a -27.3% margin in 2024Q3 to 19.3% in 2026Q2, reflecting ongoing difficulties in managing capital intensity and working capital cycles.

NEOG Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMMay'25May'24May'23May'22May'21May'20May'19May'18May'17May'16May'15May'14May'13May'12May'11May'10May'09May'08May'07May'06May'05May'04May'03May'02May'01May'00May'99May'98May'97May'96
Cash from Operations69.54M58.24M35.26M41.03M68.04M81.09M85.88M63.84M69.13M60.27M35.33M43.79M21.67M26.56M22.28M28.84M27.99M10.98M7.87M10.16M12.31M6.72M2.98M6.7M3.4M2.5M4.68M3.7M1.5M2.3M900K
Operating CF Margin %-6.51%3.82%4.99%12.91%17.31%20.54%15.41%17.37%16.82%11%15.47%8.76%12.8%12.1%16.7%19.92%9.25%7.69%11.79%17%10.71%5.37%14.41%8.26%7.15%19.89%16.67%8.11%15.03%7.2%
Operating CF Growth %87.98%65.17%-14.05%-39.7%-16.09%-5.58%34.52%-7.65%14.69%70.6%-19.32%102.1%-18.42%19.23%-22.76%3.05%154.78%39.53%-22.49%-17.5%83.17%125.49%-55.51%97.32%36.06%-46.62%26.38%146.67%-34.78%155.56%280%
Net Income-608.78M-1.09B-9.42M-22.87M48.31M60.88M59.48M60.18M63.22M43.97M36.54M33.58M28.03M27.04M22.39M22.8M17.52M13.87M12.1M9.13M7.94M5.92M5.1M4.79M3.94M3.17M3.07M2.3M2.2M1.8M-200K
Depreciation & Amortization123.35M125.67M121.23M90.47M24.13M21.04M18.4M17.62M17.06M14.69M12.18M10.65M9.18M7.41M6.17M5.33M4.43M3.89M3.52M2.84M2.42M1.7M1.4M1.14M1.07M1.3M946K900K700K600K500K
Stock-Based Compensation14.73M17.29M13.77M10.18M7.15M6.44M6.47M5.54M4.91M5.26M5.47M4.45M3.69M3.06M2.46M2.24M2.24M1.97M0000000000000
Deferred Taxes-40.17M-57.78M-27.42M-19.23M-4.7M-640K1.6M1.2M-3M-292K1.91M496K-542K287K1.34M2.25M-200K1.55M450K813K485K309K512K420K0000000
Other Non-Cash Items524.32M1.07B9.8M6.67M-2.44M0000-3.92M-2.94M-2.48M-4.76M-3.11M-1.83M-2.99M-709K-682K1.4M1.2M754K274K250K571K00-1K600K100K0-100K
Working Capital Changes56.11M-5.93M-72.68M-24.2M-4.42M-6.63M-62K-20.7M-13.05M563K-17.82M-2.9M-13.93M-8.13M-8.25M-779K4.7M-9.61M-9.59M-3.82M716K-1.48M-4.28M-213K-1.62M-1.98M657K-100K-1.5M-100K700K
Change in Receivables19.11M11.64M-20.1M-53.88M-7.8M-2.6M-2.88M-4.03M-10.23M5.04M-6M-7.25M-10.6M-2.67M-7.2M-903K-2.24M-4.08M-3.87M-1.8M-1.35M-545K-2.23B-755M0000000
Change in Inventory30.51M-16.12M-55.95M9.96M-21.07M2.45M-10.01M-10.44M-2.65M-6.97M-9.43M319K-3.53M-2.08M-3.09M-434K64K-3.7M-6.36M-1.49M-671K-1.33M-831K-1.05M-1.58M-1.12M143K300K-400K-200K500K
Change in Payables14.11M-402K13.75M18.64M20.24M-2.22M6.75M-1.46M4.38M-1.69M704K412K1.97M-1.42M2.33M1.2M3.01M-2.65M0000000000000
Cash from Investing58.57M-99.19M-29.31M201.04M-97.23M-105.56M-88.78M-119.15M-83.08M-62.14M-61.15M-28.45M-51.29M-37.95M-15.79M-28.04M-25.73M-13.97M-12.62M-4.7M-23.5M-3.23M-7.57M-7.81M-3.31M-3.71M-2.44M-1.2M-1.8M-11.4M-1.1M
Capital Expenditures-63.44M-104.59M-111.42M-65.76M-24.43M-26.71M-24.05M-14.66M-20.95M-14.58M-14.22M-9.62M-11.54M-8.9M-12.41M-7.8M-5.43M-2.84M-2.47M-4.7M-2.69M-2.69M-5.04M-2.46M-1.72M-1.1M-920K-900K-600K-700K-1.1M
CapEx % of Revenue7.29%11.69%12.06%8%4.63%5.7%5.75%3.54%5.26%4.07%4.43%3.4%4.67%4.29%6.74%4.51%3.87%2.39%2.41%5.46%3.72%4.28%9.09%5.29%4.18%3.15%3.91%4.05%3.24%4.58%8.8%
Acquisitions204K5.08M108K12.55M-38.74M-50.77M-13.16M-6.39M-468K-34.03M-42.49M-6.55M-39.27M-13.32M-4.01M0-20.3M-11.13M-10.15M0-20.66M-874K-10.03M-1.85M-3.59M-4.75M-2.65M0000
Investments-------------------------------
Other Investing121.8M000000000000000000000-5.04B-2.46B000-600K-3.7M100K0
Cash from Financing-101.21M-1.6M1.92M-118.08M6.81M33.54M29.41M13.9M22.84M25.07M15.31M11.03M19.61M12.49M6.88M12.03M6.71M2.56M5.59M6.01M11.02M-2.88M4.89M154K1.08M-136K-1.1M-2.1M300K9.2M200K
Debt Issued (Net)-100.17M-321K-420K-100M000000000000000-9.96M9.96M-3.9M3.9M0-77K-499K-49K0-100K-1.1M-100K
Equity Issued (Net)3.06M2.24M2.46M1.2M7.93M34.63M29.41M13.9M23.26M21.15M12.36M8.56M14.85M9.53M5.8M10.26M5.9M1.99M5.06M15.44M1.5M766K995K154K1.16M363K-1.06M-2.1M300K10.3M300K
Dividends Paid0000000000000000000000000000000
Share Repurchases0000000-3.13M000000000-923K00-29K-257K0-558K-315K-573K-1.33M-2.2M000
Other Financing-4.1M-3.52M-118K-19.28M-1.12M-1.09M00-423K3.92M2.94M2.48M4.76M2.96M1.08M1.77M809K564K531K531K328K250K4.89B0001K0100K00
Net Change in Cash32.19M-41.61M7.37M118.77M-31.13M9.33M24.58M-41.39M5.51M22.31M-10.8M25.39M-9.36M987K13.2M27.02M321K6.41M61K215K1.81M1.97M304K-951K1.16M-1.35M1.14M400K0100K0
Free Cash Flow41.78M-46.35M-76.16M-24.73M43.61M54.38M61.83M49.18M48.19M45.7M21.11M34.17M10.13M17.66M9.86M21.05M22.56M8.15M5.4M5.45M8.87M4.03M-2.06M4.24M1.68M1.4M3.76M2.8M900K1.6M-200K
FCF Margin %4.8%-5.18%-8.24%-3.01%8.27%11.61%14.78%11.87%12.11%12.75%6.57%12.07%4.09%8.51%5.36%12.19%16.05%6.86%5.27%6.33%12.24%6.43%-3.72%9.12%4.09%4%15.97%12.61%4.86%10.46%-1.6%
FCF Growth %194.18%39.14%-207.97%-156.71%-19.8%-12.05%25.71%2.07%5.45%116.48%-38.23%237.51%-42.68%79.08%-53.13%-6.69%176.81%50.85%-0.95%-38.49%119.81%295.64%-148.63%152.53%20.19%-62.81%34.14%211.11%-43.75%900%81.82%
FCF per Share0.19-0.21-0.35-0.130.400.510.580.470.460.450.210.340.100.180.100.220.240.090.060.060.100.04-0.020.050.020.020.060.040.010.03-0.00
FCF Conversion (FCF/Net Income)-0.07x-0.05x-3.74x-1.79x1.41x1.33x1.44x1.06x1.09x1.38x0.97x1.31x0.77x0.98x0.99x1.26x1.60x0.79x0.65x1.11x1.55x1.14x0.58x1.40x0.86x0.79x1.52x1.61x0.68x1.28x-4.50x
Interest Paid068.14M73.17M42.62M72K78K0000000000000000000000000
Taxes Paid026.54M22.3M15.47M17.24M14.97M0000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Integration-driven cash volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Earnings Quality Obscured by Amortization

As reported in recent financial filings, NEOG's operating cash flow consistently exceeds net income, with the 2026Q3 OCF/NI ratio of -1.34 highlighting a significant disconnect between GAAP accounting losses and the actual cash-generating capacity of the underlying diagnostic business units.

The persistent gap between net income and operating cash flow suggests that massive non-cash charges, likely related to the 3M Food Safety merger, are artificially depressing reported earnings. Investors should interpret this divergence as evidence that the company's cash-generating potential is currently masked by accounting-heavy amortization and integration-related expenses.

FCF Volatility Reflects Integration Challenges

Based on the provided cash flow data, NEOG's free cash flow trajectory remains highly erratic, swinging from a -27.3% margin in 2024Q3 to a positive 19.3% in 2026Q2, which indicates that the company has yet to establish a stable, predictable cash conversion cycle post-merger.

The lack of a consistent FCF trend suggests that management is still navigating the operational complexities of the combined entity. This volatility warrants caution, as it implies that the business is not yet generating the reliable free cash flow required to support its current capital structure or future growth initiatives.

Capital Intensity Remains Elevated Post-Merger

According to historical cash flow statements, NEOG's capital intensity, measured by the CapEx/Revenue ratio, peaked at 17.7% in 2025Q1 and remains elevated at 5.5% in 2026Q3, suggesting that the company is still heavily investing in infrastructure to integrate its expanded diagnostic manufacturing footprint.

The sustained level of capital expenditure indicates that the company is prioritizing asset integration and facility optimization over immediate cash preservation. Analysts should monitor whether these investments eventually lead to improved operational efficiency or if they represent a permanent increase in the capital intensity required to maintain the current product portfolio.

Working Capital Fluctuations Impair Cash Flow

As evidenced by the quarterly cash flow data, NEOG's working capital changes have been highly inconsistent, ranging from a $61.2 million outflow in 2024Q3 to a $21.5 million inflow in 2026Q1, reflecting significant instability in the company's ability to manage its operational cash cycle.

These swings in working capital suggest potential inefficiencies in inventory management or collection cycles following the merger. The inability to maintain a stable working capital profile may indicate that the company is struggling to synchronize its supply chain with the demands of its newly integrated business segments.

NEOG — Frequently Asked Questions

Quick answers to the most common questions about buying NEOG stock.

How much cash does Neogen Corporation (NEOG) generate from operations?

Neogen Corporation (NEOG) generated $58.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Neogen Corporation's free cash flow?

Neogen Corporation (NEOG) reported negative free cash flow of $46.4M in 2025, indicating capital requirements exceeded cash from operations.

What is Neogen Corporation's capital expenditure (CapEx)?

Neogen Corporation (NEOG) spent $104.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.